Pipeline
Leadership
- Management Team
- Board of Directors
Medical Affairs
News & Investors
Careers
Contact

Pipeline
Leadership
Medical Affairs
News & Investors
Careers
Contact

Management Team
Board of Directors

MEDINFO
Adverse Event
Product Quality Complaint
Research Focus
Clinical Trials
CME Grant
Investigator Initiated Study
Find your field medical director

Atopic Dermatitis
Psoriasis

RVT-502

RVT-502

December 3, 2019

Dermavant Announces First Patient Dosed in Phase 2 ...

Read More

December 6, 2018

Dermavant Sciences to Present New Data on Cerdulat ...

Read More

Recent Posts

Fortune and Great Place to Work<sup>®</sup> Name Dermavant One of the Best Small Workplaces<sup>™</sup> and Best Workplaces in Biopharma<sup>™</sup> in 2022
Dermavant to Present New Data from Phase 3 Trial Program of VTAMA<sup>®</sup> (tapinarof) cream, 1% for Adults with Plaque Psoriasis at the 2022 EADV Congress
VTAMA<sup>®</sup> (tapinarof) cream, 1% PSOARING 3 Final Data Published in <em>JAAD</em>
FDA Approves Dermavant’s VTAMA<sup>®</sup> (tapinarof) cream, 1% for the Treatment of Plaque Psoriasis in Adults: First Topical Novel Chemical Entity Launched for Psoriasis in the U.S. in 25 Years
Dermavant Showcases New Long-Term Durability and Tolerability Data from Phase 3 PSOARING 3 Trial of Tapinarof Cream for Adults with Plaque Psoriasis at the 2022 AAD Annual Meeting

Archives

Categories

Dermavant Sciences
News
RVT-201
RVT-501
RVT-502
RVT-504
Tapinarof

Find Us

Address
123 Main Street
New York, NY 10001

Hours
Monday—Friday: 9:00AM–5:00PM
Saturday & Sunday: 11:00AM–3:00PM

Copyright © 2018 Dermavant Sciences, Inc. All rights reserved.
Privacy Policy | Terms of Use

Company
Medical Information
Compliance Program

Leadership
Careers
Contact
News & Investors

Pipeline
MEDINFO
Clinical Trials
Research Focus
CME Grant

Management Team
Board of Directors

Atopic Dermatitis
Psoriasis

Company
- Leadership
  - Management Team
  - Board of Directors
- Careers
- Contact
- News & Investors
Medical Information
- Pipeline
- MEDINFO
- Clinical Trials
- Research Focus
  - Atopic Dermatitis
  - Psoriasis
- CME Grant
Compliance Program

Copyright © 2022 Dermavant Sciences, Inc. All Rights Reserved. All trademarks are the property of Dermavant Sciences, GmbH.
Privacy Policy | Terms of Use | Terms of Sale – Independent Pharmacies | Terms of Sale – Wholesalers | US Wholesalers